<A HREF="http://sc.ifeng.com/event.ng/Type=click&FlightID=21821&AdID=21594&TargetID=304&Segments=1,160,262,871&Targets=882,196,304,811&Values=34,46,51,81,100,110,204,228,238,263,305,583&RawValues=&Redirect=http://ad.cn.doubleclick.net/click;h=v2|3AFC|0|0|%2a|w;214677492;0-0;0;36519659;31-1|1;21717145|21735035|1;;%3fhttp://www-900.ibm.com/innovation/cn/healthcare/index.shtml?ca=apch_sp-20090511&me=banner&met=sp&re=ifeng&s_tact=chspb002&cm_mmc=apch_sp-20090511-chspb002-_-b-_-sp-_-ifeng" target="_blank"><IMG SRC="http://img.ifeng.com/tres/recommend/client/ibm2007/090512-ibm_finance-950x90.swf" WIDTH=950 HEIGHT=90 BORDER=0></A>

凤凰财经 > 港股 > 现金流量表 > 亿胜生物科技 (08151.HK)
港股代码：

08151 亿胜生物科技有限公司

现金流量表
单位: 港元 (元) 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
经营业务所得之现金流入/(流出)净额  3,746,697.00  -5,786,194.00  4,404.00  -2,225.00  2,832.00
投资活动之现金流入/(流出)净额  186,409.00  -4,458,212.00  -17,564.00  9,242.00  10,103.00
融资活动之现金流入/(流出)净额  5,747,630.00  23,909,920.00  5,131.00  -73.00  -97.00
现金及现金等价物增加/(减少)  9,680,736.00  13,665,514.00  -8,029.00  6,944.00  12,838.00
会计年初之现金及现金等价物  38,371,088.00  23,100,583.00  30,499.00  23,360.00  10,522.00
外汇兑换率变动之影响  1,893,465.00  1,604,991.00  631.00  194.00  --
会计年终之现金及现金等价物  49,945,289.00  38,371,088.00  23,101.00  30,498.00  23,360.00